1.Effects on electromyography activity and range of motion in lower limb from a novel hip flexor training machine under light and heavy resistance
Wei-han CHEN ; Wen-hsuan PAN ; Wen-wen YANG ; Pao-hung CHUNG ; Chiang LIU
Journal of Medical Biomechanics 2012;27(4):E398-E402
Objective To investigate the effect of a novel hip flexor training machine on muscle activation and range of motion (ROM) in lower limb under the condition of different resistances. Methods Six volunteers performed consecutive rightly hip flexion and extension for 30 times under light or heavy resistance randomly on the training machine, and the muscle activity and ROM in lower limb during the movement were measured at the same time. Results The muscle activation of rectus abdominal, hip flexor muscles, gluteus maximum, rectus femoris and biceps femoris under heavy resistance was significantly higher than that under light resistance (P<0.05); the muscle activation of rectus abdominis, hip flexor muscles and rectus femoris at during the last 3 times were significantly higher than that at of the first 3 times under heavy resistance (P<0.05); under light resistance, only the muscle activation of erector spinae and rectus femoris during the last 3 times were significantly higher than that of the first 3 times. The ROM and angle of hip extension under heavy resistance were significantly smaller than those under light resistance. Conclusions Under the rational ROM of hip joint, this new hip flexor training machine can stimulate the hip flexion and extension muscles and other co-contraction muscles to accomplish the movement, especially under the condition of heavy resistance.
2.The Influence of Reconstruction Algorithm and Heart Rate on Coronary Artery Image Quality and Stenosis Detection at 64-Detector Cardiac CT.
Yi Ting WANG ; Chung Yi YANG ; Jong Kai HSIAO ; Hon Man LIU ; Wen Jen LEE ; Yun SHEN
Korean Journal of Radiology 2009;10(3):227-234
OBJECTIVE: We wanted to evaluate the impact of two reconstruction algorithms (halfscan and multisector) on the image quality and the accuracy of measuring the severity of coronary stenoses by using a pulsating cardiac phantom with different heart rates (HRs). MATERIALS AND METHODS: Simulated coronary arteries with different stenotic severities (25, 50, 75%) and different luminal diameters (3, 4, 5 mm) were scanned with a fixed pitch of 0.16 and a 0.35 second gantry rotation time on a 64-slice multidetector CT. Both reconstruction algorithms (halfscan and multisector) were applied to HRs of 40-120 beats per minute (bpm) at 10 bpm intervals. Three experienced radiologists visually assessed the image quality and they manually measured the stenotic severity. RESULTS: Fewer measurement errors occurred with multisector reconstruction (p = 0.05), a slower HR (p < 0.001) and a larger luminal diameter (p = 0.014); measurement errors were not related with the observers or the stenotic severity. There was no significant difference in measurements as for the reconstruction algorithms below an HR of 70 bpm. More nonassessable segments were visualized with halfscan reconstruction (p = 0.004) and higher HRs (p < 0.001). Halfscan reconstruction had better quality scores when the HR was below 60 bpm, while multisector reconstruction had better quality scores when the HR was above 90 bpm. For the HRs between 60 and 90 bpm, both reconstruction modes had similar quality scores. With excluding the nonassessable segments, both reconstruction algorithms achieved a similar mean measured stenotic severity and similar standard deviations. CONCLUSION: At a higher HR (above 90 bpm), multisector reconstruction had better temporal resolution, fewer nonassessable segments, better quality scores and better accuracy of measuring the stenotic severity in this phantom study.
*Algorithms
;
Artifacts
;
Computer Simulation
;
Coronary Angiography/*methods
;
Coronary Stenosis/*radiography
;
Electrocardiography
;
*Heart Rate
;
Image Processing, Computer-Assisted/*methods
;
Models, Cardiovascular
;
Observer Variation
;
Phantoms, Imaging
;
Reproducibility of Results
;
Severity of Illness Index
;
Tomography, Spiral Computed/*methods
3.Exendin-4 improves resistance to Listeria monocytogenes infection in diabetic db/db mice.
Hsien Yueh LIU ; Chih Yao CHUNG ; Wen Chin YANG ; Chih Lung LIANG ; Chi Young WANG ; Chih Yu CHANG ; Cicero Lee Tian CHANG
Journal of Veterinary Science 2012;13(3):245-252
The incidence of diabetes mellitus is increasing among companion animals. This disease has similar characteristics in both humans and animals. Diabetes is frequently identified as an independent risk factor for infections associated with increased mortality. In the present study, homozygous diabetic (db/db) mice were infected with Listeria (L.) monocytogenes and then treated with the anti-diabetic drug exendin-4, a glucagon-like peptide 1 analogue. In aged db/db mice, decreased CD11b+ macrophage populations with higher lipid content and lower phagocytic activity were observed. Exendin-4 lowered high lipid levels and enhanced phagocytosis in macrophages from db/db mice infected with L. monocytogenes. Exendin-4 also ameliorated obesity and hyperglycemia, and improved ex vivo bacteria clearance by macrophages in the animals. Liver histology examined during L. monocytogenes infection indicated that abscess formation was much milder in exendin-4-treated db/db mice than in the control animals. Moreover, mechanistic studies demonstrated that expression of ATP binding cassette transporter 1, a sterol transporter, was higher in macrophages isolated from the exendin-4-treated db/db mice. Overall, our results suggest that exendin-4 decreases the risk of infection in diabetic animals by modifying the interaction between intracellular lipids and phagocytic macrophages.
ATP-Binding Cassette Transporters/metabolism
;
Age Factors
;
Animals
;
Blood Chemical Analysis
;
Cholesterol/metabolism
;
Diabetes Mellitus, Type 2/*drug therapy/genetics
;
Dyslipidemias/drug therapy/genetics
;
Female
;
Hyperglycemia/drug therapy/genetics
;
Hypoglycemic Agents/*therapeutic use
;
Injections, Intraperitoneal
;
*Lipid Metabolism/drug effects
;
Listeria monocytogenes/*drug effects/immunology
;
Listeriosis/*drug therapy/immunology/microbiology
;
Macrophages/drug effects/*metabolism
;
Mice
;
Obesity/drug therapy/genetics
;
Peptides/*therapeutic use
;
Phagocytosis/drug effects
;
Venoms/*therapeutic use
4.Expression and significance of clusterin in normal prostate, benign prostate hyperplasia and prostate cancer.
Li-qun ZHOU ; Xue-zhen YANG ; Li ZENG ; Li-li LIANG ; Xin-yu YANG ; Liang REN ; Lee CHUNG ; Zhi-wen ZHANG ; Yan-qun NA ; Fang-liu GU ; Ying-lu GUO
Chinese Journal of Surgery 2003;41(2):93-95
OBJECTIVETo investigate the expression and significance of Clusterin in normal prostate, benign prostate hyperplasia (BPH) and prostate cancer.
METHODSClusterin expression in samples of 12 normal prostate, 15 BPH, and 56 prostate cancer were studied by immunohistochemical stain.
RESULTSOf 83 cases, 67 are positive or weak positive (81%). The rate of positive or weak positive for normal prostate, BPH and prostate cancer was 17% (2/12), 73% (11/15), and 96% (54/56) respectively. The expression level of Clusterin in prostate cancer was much higher than in normal prostate (t = 8.82, P < 0.01). BPH (t = 7.63, P < 0.01) was related positively with pathological grade (r = 0.649, P < 0.01) and stage (r = 0.609, P < 0.01) of prostate cancer.
CONCLUSIONClusterin may play an important role in the biological characteristics of prostate cancer by the anti-apoptosis pathway.
Apoptosis ; Clusterin ; metabolism ; physiology ; Female ; Humans ; Immunohistochemistry ; Male ; Prostate ; metabolism ; Prostatic Hyperplasia ; metabolism ; Prostatic Neoplasms ; metabolism ; pathology ; physiopathology
5.Lipopolysaccharide-induced Autophagy Increases SOX2-positive Astrocytes While Decreasing Neuronal Differentiation in the Adult Hippocampus
Wen-Chung LIU ; Chih-Wei WU ; Mu-Hui FU ; You-Lin TAIN ; Chih-Kuang LIANG ; I-Chun CHEN ; Chun-Ying HUNG ; Yu-Chi LEE ; Kay L.H. WU
Experimental Neurobiology 2022;31(5):307-323
Inflammation alters the neural stem cell (NSC) lineage from neuronal to astrogliogenesis. However, the underlying mechanism is elusive. Autophagy contributes to the decline in adult hippocampal neurogenesis under E. coli lipopolysaccharide (LPS) stimulation. SRY-box transcription Factor 2 (SOX2) is critical for NSC self-renewal and proliferation. In this study, we investigated the role of SOX2 in induced autophagy and hippocampal adult neurogenesis under LPS stimulation. LPS (5 ng•100 g -1 •hour -1 for 7 days) was intraperitoneally infused into male Sprague–Dawley rats (8 weeks old) to induce mild systemic inflammation. Beclin 1 and autophagy protein 12 (Atg12) were significantly upregulated concurrent with decreased numbers of Ki67- and doublecortin (DCX)-positive cells in the dentate gyrus. Synchronically, the levels of phospho(p)-mTOR, the p-mTOR/mTOR ratio, p-P85s6k, and the p-P85s6k/P85s6k ratio were suppressed. In contrast, SOX2 expression was increased. The fluorescence micrographs indicated that the colocalization of Beclin 1 and SOX2 was increased in the subgranular zone (SGZ) of the dentate gyrus. Moreover, increased S100β-positive astrocytes were colocalized with SOX2 in the SGZ. Intracerebroventricular infusion of 3-methyladenine (an autophagy inhibitor) effectively prevented the increases in Beclin 1, Atg12, and SOX2. The SOX2 + -Beclin 1 + and SOX2 + -S100β + cells were reduced. The levels of p-mTOR and p-P85s6k were enhanced. Most importantly, the number of DCX-positive cells was preserved. Altogether, these data suggest that LPS induced autophagy to inactivate the mTOR/P85s6k pathway, resulting in a decline in neural differentiation. SOX2 was upregulated to facilitate the NSC lineage, while the autophagy milieu could switch the SOX2-induced NSC lineage from neurogenesis to astrogliogenesis.
6.The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells.
Chun Yu LIU ; Tzu Ting HUANG ; Pei Yi CHU ; Chun Teng HUANG ; Chia Han LEE ; Wan Lun WANG ; Ka Yi LAU ; Wen Chun TSAI ; Tzu I CHAO ; Jung Chen SU ; Ming Huang CHEN ; Chung Wai SHIAU ; Ling Ming TSENG ; Kuen Feng CHEN
Experimental & Molecular Medicine 2017;49(8):e366-
Triple-negative breast cancer (TNBC) remains difficult to treat and urgently needs new therapeutic options. Nintedanib, a multikinase inhibitor, has exhibited efficacy in early clinical trials for HER2-negative breast cancer. In this study, we examined a new molecular mechanism of nintedanib in TNBC. The results demonstrated that nintedanib enhanced TNBC cell apoptosis, which was accompanied by a reduction of p-STAT3 and its downstream proteins. STAT3 overexpression suppressed nintedanib-mediated apoptosis and further increased the activity of purified SHP-1 protein. Moreover, treatment with either a specific inhibitor of SHP-1 or SHP-1-targeted siRNA reduced the apoptotic effects of nintedanib, which validates the role of SHP-1 in nintedanib-mediated apoptosis. Furthermore, nintedanib-induced apoptosis was attenuated in TNBC cells expressing SHP-1 mutants with constantly open conformations, suggesting that the autoinhibitory mechanism of SHP-1 attenuated the effects of nintedanib. Importantly, nintedanib significantly inhibited tumor growth via the SHP-1/p-STAT3 pathway. Clinically, SHP-1 levels were downregulated, whereas p-STAT3 was upregulated in tumor tissues, and SHP-1 transcripts were associated with improved disease-free survival in TNBC patients. Our findings revealed that nintedanib induces TNBC apoptosis by acting as a SHP-1 agonist, suggesting that targeting STAT3 by enhancing SHP-1 expression could be a viable therapeutic strategy against TNBC.
Apoptosis*
;
Breast Neoplasms
;
Disease-Free Survival
;
Humans
;
Protein-Tyrosine Kinases*
;
RNA, Small Interfering
;
Triple Negative Breast Neoplasms*
;
Tyrosine*
7.Chronic Kidney Disease and Associated Cardiovascular Risk Factors in Chinese with Type 2 Diabetes.
Qing Lin LOU ; Xiao Jun OUYANG ; Liu Bao GU ; Yong Zhen MO ; Ronald MA ; Jennifer NAN ; Alice KONG ; Wing Yee SO ; Gary KO ; Juliana CHAN ; Chun Chung CHOW ; Rong Wen BIAN
Diabetes & Metabolism Journal 2012;36(6):433-442
BACKGROUND: To determine the frequency of chronic kidney disease (CKD) and its associated risk factors in Chinese type 2 diabetic patients, we conducted a cross-sectional study in Nanjing, China, in the period between January 2008 and December 2009. METHODS: Patients with type 2 diabetes under the care by Jiangsu Province Official Hospital, Nanjing, China were invited for assessment. CKD was defined as the presence of albuminuria or estimated glomerular filtration rate <60 mL/min/1.73 m2. Albuminuria was defined as urinary albumin-to-creatinine ratio > or =30 mg/g. RESULTS: We recruited 1,521 urban Chinese patients with type 2 diabetes (mean age, 63.9+/-12.0 years). The frequency of CKD and albuminuria was 31.0% and 28.9%, respectively. After adjusted by age and sex, hypertension, anemia and duration of diabetes were significantly associated with CKD with odds ratio (95% confidence interval) being 1.93 (1.28 to 2.93), 1.70 (1.09 to 2.64), and 1.03 (1.00 to 1.06), respectively. CONCLUSION: In conclusion, CKD was common in the urban Nanjing Chinese with type 2 diabetes. Strategies to prevent or delay progression of kidney disease in diabetes should be carried out at the early disease course of type 2 diabetes.
Albuminuria
;
Anemia
;
Asian Continental Ancestry Group
;
China
;
Cross-Sectional Studies
;
Diabetes Mellitus, Type 2
;
Glomerular Filtration Rate
;
Humans
;
Hypertension
;
Kidney Diseases
;
Odds Ratio
;
Renal Insufficiency, Chronic
;
Risk Factors
8.A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder.
Yuan Hwa CHOU ; Po Chung CHU ; Szu Wei WU ; Jen Chin LEE ; Yi Hsuan LEE ; I Wen SUN ; Chen Lin CHANG ; Chien Liang HUANG ; I Chao LIU ; Chia Fen TSAI ; Yung Chieh YEN
Clinical Psychopharmacology and Neuroscience 2015;13(2):121-128
Bipolar disorder (BD) is a major psychiatric disorder that is easily misdiagnosed. Patient adherence to a treatment regimen is of utmost importance for successful outcomes in BD. Several trials of antipsychotics suggested that depot antipsychotics, including long-acting first- and second-generation agents, are effective in preventing non-adherence, partial adherence, and in reducing relapse in BD. Various long-acting injectable (LAI) antipsychotics are available, including fluphenazine decanoate, haloperidol decanoate, olanzapine pamoate, risperidone microspheres, paliperidone palmitate, and aripiprazole monohydrate. Due to the increasing number of BD patients receiving LAI antipsychotics, treatment guidelines have been developed. However, the clinical applicability of LAI antipsychotics remains a global cause for concern, particularly in Asian countries. Expert physicians from Taiwan participated in a consensus meeting, which was held to review key areas based on both current literature and clinical practice. The purpose of this meeting was to generate a practical and implementable set of recommendations for LAI antipsychotic use to treat BD; target patient groups, dosage, administration, and adverse effects were considered. Experts recommended using LAI antipsychotics in patients with schizophrenia, rapid cycling BD, BD I, and bipolar-type schizoaffective disorder. LAI antipsychotic use was recommended in BD patients with the following characteristics: multiple episodes and low adherence; seldom yet serious episodes; low adherence potential per a physician's clinical judgment; preference for injectable agents over oral agents; and multiple oral agent users still experiencing residual symptoms.
Antipsychotic Agents*
;
Asian Continental Ancestry Group
;
Bipolar Disorder*
;
Consensus*
;
Fluphenazine
;
Haloperidol
;
Humans
;
Judgment
;
Microspheres
;
Patient Compliance
;
Psychotic Disorders
;
Recurrence
;
Risperidone
;
Schizophrenia
;
Taiwan
;
Aripiprazole
;
Paliperidone Palmitate
9.Validity of Glycated Hemoglobin in Screening and Diagnosing Type 2 Diabetes Mellitus in Chinese Subjects.
Yun YU ; Xiao Jun OUYANG ; Qing Lin LOU ; Liu Bao GU ; Yong Zhen MO ; Gary T KO ; Chun Chung CHOW ; Wing Yee SO ; Ronald MA ; Alice KONG ; Nicola BROWN ; Jennifer NAN ; Juliana CHAN ; Rong Wen BIAN
The Korean Journal of Internal Medicine 2012;27(1):41-46
BACKGROUND/AIMS: The application of glycated hemoglobin (HbA1c) for the diagnosis of diabetes is currently under extensive discussion. In this study, we explored the validity of using HbA1c as a screening and diagnostic test in Chinese subjects recruited in Nanjing, China. METHODS: In total, 497 subjects (361 men and 136 women) with fasting plasma glucose (PG) > or = 5.6 mmol/L were recruited to undergo the oral glucose tolerance test (OGTT) and HbA1c test. Plasma lipid, uric acid, and blood pressure were also measured. RESULTS: Using a receiver operating characteristic curve, the optimal cutoff point of HbA1c related to diabetes diagnosed by the OGTT was 6.3%, with a sensitivity and specificity of 79.6% and 82.2%, respectively, and the area under the curve was 0.87 (95% confidence interval, 0.83 to 0.92). A HbA1c level of 6.5% had a sensitivity and specificity of 62.7% and 93.5%, respectively. When comparing the HbA1c > or = 6.5% or OGTT methods for diagnosing diabetes, the former group had significantly higher HbA1c levels and lower levels of fasting and 2-hour PG than the latter group. No significant difference was observed in the other metabolism indexes between the two groups. CONCLUSIONS: Our results suggest that HbA1c > or = 6.5% has reasonably good specificity for diagnosing diabetes in Chinese subjects, which is in concordance with the American Diabetes Association recommendations.
Aged
;
Analysis of Variance
;
*Asian Continental Ancestry Group
;
Biological Markers/blood
;
Blood Glucose/analysis
;
China/epidemiology
;
*Chromatography, High Pressure Liquid/standards
;
*Chromatography, Ion Exchange/standards
;
Diabetes Mellitus, Type 2/blood/*diagnosis/ethnology
;
Fasting/blood
;
Female
;
Glucose Tolerance Test/standards
;
Hemoglobin A, Glycosylated/*analysis
;
Humans
;
Male
;
Mass Screening/*methods/standards
;
Middle Aged
;
Predictive Value of Tests
;
ROC Curve
;
Reference Standards
;
Reproducibility of Results
;
Sensitivity and Specificity
10.Study on international standard multilingual nomenclature of Chinese medicine.
Kui WANG ; Lu LIU ; Wei LI ; Da-zhuo SHI ; Wen-ying ZENG ; Mian-sheng ZHU ; Michel ANGLES ; Jean-Raymond ATTALI ; Pedro CHOY ; Joao CHOY ; Chi-haur WU ; Fu-han ZHAI ; Maria Calduch RAMON ; Ching CHUNG
Chinese journal of integrative medicine 2010;16(2):176-179
The International Standard Chinese-English Basic Nomenclature of Chinese medicine (ISN) was released in 2007, a nomenclature list consisting of 6 500 Chinese medical terms. ISN was the culmination of several years of collaborative diligent work of over 200 specialists who represent Chinese medicine in 68 countries. The overall goal for devising standard English nomenclature for Chinese medicine is to develop a practical international standard nomenclature for Chinese medical basic terms, to make it compatible with contemporary research and educational standards in the globalized health care service. In this article, provided is an overview of principles and methods for the multilingual translations, the processes behind the particular content of the Chinese-English ISN and an introduction to the ongoing new projects, i.e. the multilingual versions of ISN (International Standards of Chinese-Spanish, Chinese-French and Chinese-Portuguese Basic Nomenclature of Chinese Medicine).
Anatomy
;
standards
;
Drugs, Chinese Herbal
;
standards
;
Humans
;
International Cooperation
;
Medicine, Chinese Traditional
;
methods
;
standards
;
Multilingualism
;
Publications
;
standards
;
Reference Standards
;
Terminology as Topic
;
Translating
;
Vocabulary, Controlled
;
World Health Organization